The University of Oxford, that tops the league table for clinical, preclinical and health subjects, is that the solely non-American establishment at the summit of any of the topic tables.
Oxford will trace the study of drugs there back to the 14th century, though clinical student teaching began throughout the Second World War when medical students were evacuated from London throughout the Nazi bombardment of town.
Its medical courses are maybe best known for being very exhausting to induce into: in August, student Prina Shah created the headlines when she was rejected despite her four A* grades at A level. In 2000, Oxford's rejection of equally starred state-school pupil Laura Spence sparked a political storm: Gordon Brown, the long run prime minister, accused its admissions tutors of elitism when she did not win an area to browse drugs.
But it's in medical analysis where Oxford extremely stands out, bolstered by the biggest cluster of overseas analysis activity across the whole university - the Africa and Asia Tropical drugs network.
And the future appearance bright, too: in August, the establishment was awarded well over £100 million over 5 years in 3 separate tranches by the National Institute for Health analysis to fund analysis partnerships between the university and native hospitals.
Oxford heads an inventory of eight British universities within the prime fifty, with four within the prime ten as well as Imperial faculty London and also the University of Cambridge.
Three Asian representatives create the table - the University of Tokyo, the University of Hong Kong and also the National University of Singapore.
Hong Kong's medical college was founded by the London Missionary Society in 1887 and is currently the biggest of the university's schools.
